CLINICAL_TRIALS
withdrawal
· 2017-02-15
Clinical Trial Update: Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression [Phase 1]
Summary
A Phase 1 clinical trial evaluating pancreatic islet cell transplantation after kidney transplantation using a novel immunosuppression approach has been withdra…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Baylor Research Institute | Conditions: Islet Cell Transplantation, Type 1 Diabetes | Phase 1 | Status: WITHDRAWN